The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gaurang Thakker
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Gaurang Rameshchandra Thakker acquired 18,000 equity shares (0.26%) of Aptus Pharma Limited on 11 May 2026 through open market. Before the acquisition, he held 5,75,000 shares (8.38%). After the acquisition, his holding increased to 5,93,000 shares (8.64%) out of total 68,60,000 equity shares. The mode of acquisition is listed as NA (off-market/inter-se transfer among Promoter Group). This is a disclosure under SEBI SAST Regulations requiring disclosure when a promoter acquires shares beyond certain thresholds.
This is a minor promoter stake increase of 0.26%. While it signals confidence in the company, the absolute holding remains modest at 8.64%, and no takeover threshold is currently threatened.